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Abstract
Background: The members of the genus Acinetobacter are Gram-negative cocobacilli that are frequently found in
the environment but also in the hospital setting where they have been associated with outbreaks of nosocomial
infections. Among them, Acinetobacter baumannii has emerged as the most common pathogenic species involved
in hospital-acquired infections. One reason for this emergence may be its persistence in the hospital wards, in
particular in the intensive care unit; this persistence could be partially explained by the capacity of these
microorganisms to form biofilm. Therefore, our main objective was to study the prevalence of the two main types
of biofilm formed by the most relevant Acinetobacter species, comparing biofilm formation between the different
species.
Findings: Biofilm formation at the air-liquid and solid-liquid interfaces was investigated in different Acinetobacter
spp. and it appeared to be generally more important at 25°C than at 37°C. The biofilm formation at the solid-liquid
interface by the members of the ACB-complex was at least 3 times higher than the other species (80-91% versus
5-24%). In addition, only the isolates belonging to this complex were able to form biofilm at the air-liquid interface;
between 9% and 36% of the tested isolates formed this type of pellicle. Finally, within the ACB-complex, the
biofilm formed at the air-liquid interface was almost 4 times higher for A. baumannii and Acinetobacter G13TU than
for Acinetobacter G3 (36%, 27% & 9% respectively).
Conclusions: Overall, this study has shown the capacity of the Acinetobacter spp to form two different types of
biofilm: solid-liquid and air-liquid interfaces. This ability was generally higher at 25°C which might contribute to
their persistence in the inanimate hospital environment. Our work has also demonstrated for the first time the
ability of the members of the ACB-complex to form biofilm at the air-liquid interface, a feature that was not
observed in other Acinetobacter species.
Findings
The observation of natural habitats has shown that bac-
teria generally aggregate in biofilm structures to persist
[1]. Biofilm is an association of microbial cells which are
surrounded by a matrix of polysaccharide material; this
structure is an optimal environment for genetic material
exchange between the different microorganisms [2]. Bio-
film formation has been linked to the survival of patho-
genic bacteria in the hospital environment and it has
been connected to infections associated with indwelling
medical devices. Indeed, biofilm bacterial communities
confer a protection from environmental hazards [1,3].
The surface colonization can take place either at the
solid-liquid interface (SLI-biofilm) or at the air-liquid
interface (ALI-biofilm) where it forms a pellicle on the
t o po ft h el i q u i dm e d i aa so b s e r v e di no t h e rm i c r o o r -
ganisms such as Pseudomonas aeruginosa or Salmonella
spp. [4,5].
The members of the genus Acinetobacter are ubiqui-
tous Gram-negative cocobacilli that are frequently found
in the environment but also in the hospital setting
where they have been associated with outbreaks of
nosocomial infections [6]. The so-called Acinetobacter
calcoaceticus - Acinetobacter baumannii (ACB) complex
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any medium, provided the original work is properly cited.contains phenotypically closely related species, i.e. the
clinically most important species, A. baumannii, Acine-
tobacter Genospecies 3 and Acinetobacter Genospecies
1 3 T U ,a l s or e f e r r e dt oa st h eA. baumanni group, and
the environmental species A. calcoaceticus [7]. Although
these species are very difficult to differentiate in the
laboratory, their importance in the clinical environment
is clearly different: A. baumannii and Acinetobacter Gen-
ospecies 13TU are responsible for most of the infections
while Acinetobacter Genospecies 3 is less often associated
with disease. On the other hand, A. calcoaceticus is
mainly an environmental microorganism rarely involved
in human infections [7]. Among them, A. baumannii has
emerged as the most common pathogenic species
involved in hospital-acquired infections [6,8-10]; this
multiresistant opportunistic pathogen can survive on
nutrient-limited surfaces for several days, even in dry
conditions and in the harsh hospital environment [11].
O n er e a s o nf o rt h i se m e r g e n c em a yb ei t sp e r s i s t e n c ei n
the hospital wards, in particular in the intensive care
unit; this persistence could be partially explained by the
capacity of these microorganisms to form biofilm. There-
fore, our main objective was to study the prevalence of
the two main types of biofilm formed by the most rele-
vant Acinetobacter species. Overall, this study has shown
the capacity of the members of the ACB-complex to
form two different types of biofilm (SLI and ALI), and it
revealed that biofilm formation increased at 25°C, a con-
dition that might contribute to their persistence in the
hospital environment.
Bacterial strains
This study has investigated the ALI and SLI-biofilm for-
mation in different Acinetobacter spp.: 64 clonally unre-
lated A. baumannii clinical isolates collected during the
GEIH-Ab2000 project [12]; Acinetobacter johnsonii (n =
34); Acinetobacter lwoffii (n = 26); Acinetobacter radio-
resistens (n = 20); Acinetobacter Genospecies 3 (n = 46);
Acinetobacter Genospecies 13TU (n = 60); A. calcoaceti-
cus (n = 10); Acinetobacter junii (n = 5). The Acineto-
bacter spp. other than A. baumannii were mainly
recovered from catheter-related bloodstream infections
and from the skin of patients outside the ICU and of
healthy controls [13-15]. Both biofilm analyses were car-
ried out on all the isolates in parallel.
SLI-Biofilm formation
SLI-biofilm formation was performed in 96-well plates;
biofilm formation was determined in Mueller Hinton
broth (Oxoid, France) using an initial OD600 of 0.01 and
incubated at 25°C or 37°C for 48 h without shaking.
Two wells were left uninoculated and used as negative
controls. After checking that all the isolates had grown
at a similar rate, the culture media was removed by
inversion and the wells were washed twice with distilled
water. The biofilm was stained with 0.5% crystal violet
(w/v) for 20 minutes at room temperature and the wells
were washed again to remove the unbound crystal vio-
let. Biofilm formation was finally quantified at 550 nm
after solubilisation with 95% ethanol. The bacterial iso-
lates were considered to be positive for SLI-biofilm for-
mation when the readings obtained were at least 3 times
greater than the negative control.
ALI-Biofilm formation
ALI-biofilm formation was performed in 5 ml polystyr-
ene tubes with a diameter of 12.8 mm; biofilm forma-
tion was determined in Mueller Hinton broth (Oxoid,
France) using an initial OD600 of 0.01 and incubated at
25°C or 37°C for 72 h without shaking. Positive ALI-
biofilm samples were identified visually (Figure 1); the
isolates were considered positive when a pellicle was
covering the whole liquid surface.
Data analysis
All the experiments were performed in duplicate at two
independent time-points. The percentages of isolates
producing biofilm were compared by the chi squared
test, or the Fisher exact test, as appropriate. A 2- tailed
P value < 0.05 was considered significant. The percen-
tage of isolates of the various Acinetobacter spp. produ-
cing biofilm is illustrated in Table 1.
Results and discussion
As shown in Table 1 SLI-biofilm was more frequently
produced at both 25°C and 37°C in Acinetobacter
Genospecies 3, Acinetobacter Genospecies 13TU, and
A. baumannii than in A. johnsonii, A. lwoffii,a n d
A. radioresistens (p < 0.05 for all comparisons). Thus,
Figure 1 ALI-biofilm formation by A. baumannii.a )t h ep o s i t i v e
strain forms a pellicle on the top of the liquid media and the
culture broth remains transparent; b) pellicle observed from above;
c) inversed tube shows the pellicle strength.
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persistence of the three former species in hospitals and
their involvement in nosocomial infections. Moreover,
in a previous study (using the same collection of
A. baumannii clinical isolates), Rodriguez-Baño et al.
[16] showed that 63% of A. baumannii clinical isolates
formed SLI-biofilm at 37°C. Based on these results, our
study revealed that the rates of SLI-biofilm formation
obtained for Acinetobacter Genospecies 13TU and A.
baumannii were similar, as well as their variation related
to the temperature (higher at 25°C than at 37°C). Like-
wise, ALI-biofilm was significantly more frequent at
both 25°C and 37°C in Acinetobacter Genospecies 13TU
and A. baumannii than in A. johnsonii, A. lwoffii, A.
radioresistens,a n dAcinetobacter Genospecies 3 (p <
0.05). Overall, this similar behaviour in biofilm forma-
tion between A. baumannii and Acinetobacter G13TU is
coherent with the fact that these two species are the
most commonly found in the hospital.
Our results showed (see Table 1) that ALI-biofilm was
mainly formed by the members of the ACB-complex.
Although A. junii had some capacity to form this charac-
teristic biofilm, the number of isolates studied was too
small to draw conclusions. By contrast, as a member of
the ACB-complex, A. calcoaceticus has shown a different
pattern at 37°C with a complete absence of ALI-biofilm
formation together with a reduced ability to form SLI-bio-
film, both of which could be explained by the fact that this
species’ natural habitat is the environment where lower
temperatures usually prevail.
Finally, as biofilm formation generally predominated at
25°C rather than 37°C, this mechanism could explain the
observed persistence of the members of the A. baumannii
group in the inanimate hospital environment. Previous
studies have already reported that the members of
the A. baumannii group and especially A. baumannii sur-
vive desiccation better than other Acinetobacter spp.,
comparing the survival rate of A. baumannii to those
obtained for Staphylococcus aureus [7,17]. In addition, in a
recent study, Wisplinghoff et al showed that all disinfec-
tants tested inhibited the growth of A. baumannii [18]
which suggests that these microorganisms in their plank-
tonic state are susceptible to most disinfectants. As already
demonstrated for other bacterial species, extracellular poly-
meric substances from the biofilm matrix play an impor-
tant role in the resistance and tolerance to dehydration
[19], suggesting that biofilm formation contributes to the
ability of A. baumannii, and possibly the other members of
the A. baumannii group, to survive better in the hospital
environment and to resist the action of disinfectants.
For A. baumannii, SLI-biofilm has already been
described in several reports [20-22] and it has been linked
to some device-associated infections [16]. Indeed, de Breij
et al [21] have recently compared SLI-biofilm formation
by the members of the ACB complex and concluded that
there was no difference between clinically relevant and
less-relevant Acinetobacter strains and species; in the same
way, no temperature related differences were found for
biofilm formation. Our results slightly differ from theirs
possibly due to the higher number of strains and species
analysed. They suggested a reduced biofilm formation for
the Acinetobacter Genospecies 13TU although only 3 iso-
lates had been studied; by contrast, after studying 60 iso-
lates, our results clearly show that the behaviour for
biofilm formation of this species is highly related to
A. baumannii. On the other hand, although we have only
studied 10 A. calcoaceticus isolates, the results also indi-
cate an association between biofilm and temperature in
this non-pathogenic species, a tendency that can be
observed in most of the analysed species. The comparison
with other non-pathogenic species outside the
ACB-complex has shown a relevant difference for biofilm
formation that was even increased when looking at the
ALI-biofilm formation, an ability that to our knowledge
has never been described in clinical isolates of the Acineto-
bacter spp.
In summary, the members of the A. baumannii group
have a higher ability to form SLI-and ALI-biofilm than
other less clinically related species. Nevertheless, A. calcoa-
ceticus, the environmental representative of the ACB-com-
plex, showed a reduced biofilm formation at 37°C when
compared to the other members of this complex. This fea-
ture could be connected to the higher colonization rate of
patients by pathogenic Acinetobacter species (mainly A.
baumannii and Acinetobacter Genospecie 13TU), and prob-
ably contributing to the increased risk of clinical infection.
Consent
Due to the observational and retrospective design of the
study, the Ethic Committee of the participating centres
waived the need for obtaining written informed consent.
Table 1 SLI and ALI-biofilm formation in Acinetobacter
spp
ALI-Biofilm SLI-Biofilm
25°C 37°C 25°C 37°C
A. baumannii (n = 64) 23 (35.9) 11 (12.2) 52 (81.3) (16)
a
Acinetobacter G3 (n = 46) 4 (8.7) 1 (2.2) 42 (91) 42 (91)
Acinetobacter G13TU (n = 60) 16 (26.7) 9 (15) 48 (80) 34 (56.7)
A. johnsonii (n = 34) 0 0 8 (23.5) 5 (14.7)
A. lwoffii (n = 26) 0 0 3 (11.5) 3 (11.5)
A. radioresistens (n = 20) 0 0 1 (5) 3 (15)
A. calcoaceticus (n = 10) 3 (30) 0 7 (70) 2 (20)
A. junii (n = 5) 3 (60) 3 (60) 3 (60) 2 (40)
Data are expressed as number (percentage) of isolates.
a The percentage of SLI-Biofilm formation in this collection of A. baumannii
clinical isolates has already been published by Rodriguez-Baño et al (16); this
study showed that 63% of the clinical isolates were forming SLI-biofilm at 37°C.
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